SSKN vs. CTCX, CTSO, ICCM, LUCD, XAIR, NUVO, AMIX, DRIO, DXR, and ICAD
Should you be buying STRATA Skin Sciences stock or one of its competitors? The main competitors of STRATA Skin Sciences include Carmell (CTCX), Cytosorbents (CTSO), IceCure Medical (ICCM), Lucid Diagnostics (LUCD), Beyond Air (XAIR), Holdco Nuvo Group D.G (NUVO), Autonomix Medical (AMIX), DarioHealth (DRIO), Daxor (DXR), and iCAD (ICAD). These companies are all part of the "surgical & medical instruments" industry.
STRATA Skin Sciences (NASDAQ:SSKN) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends, community ranking and institutional ownership.
Carmell has a net margin of 0.00% compared to STRATA Skin Sciences' net margin of -34.92%. STRATA Skin Sciences' return on equity of -65.76% beat Carmell's return on equity.
32.4% of STRATA Skin Sciences shares are held by institutional investors. Comparatively, 24.2% of Carmell shares are held by institutional investors. 40.4% of STRATA Skin Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
STRATA Skin Sciences has a beta of 1.53, indicating that its share price is 53% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500.
STRATA Skin Sciences has higher revenue and earnings than Carmell.
STRATA Skin Sciences presently has a consensus target price of $3.80, suggesting a potential upside of 923.16%. Given STRATA Skin Sciences' higher probable upside, equities analysts clearly believe STRATA Skin Sciences is more favorable than Carmell.
STRATA Skin Sciences received 223 more outperform votes than Carmell when rated by MarketBeat users.
In the previous week, Carmell had 2 more articles in the media than STRATA Skin Sciences. MarketBeat recorded 4 mentions for Carmell and 2 mentions for STRATA Skin Sciences. Carmell's average media sentiment score of 0.58 beat STRATA Skin Sciences' score of 0.29 indicating that Carmell is being referred to more favorably in the news media.
Summary
STRATA Skin Sciences beats Carmell on 9 of the 12 factors compared between the two stocks.
Get STRATA Skin Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
STRATA Skin Sciences Competitors List
Related Companies and Tools
